Back
NovoCure Stock Predictions

Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
NVCR
NovoCure
Last Price:
$22.47
Seasonality Move:
8.65%
7 Day Trial
ALL ACCESS PASS
$
7

10 Stellar Stocks - get the names here
Learn their names here. FREENovoCure Stock Forecast
-
Over the next 52 weeks, NovoCure has on average historically risen by 48.6% based on the past 9 years of stock performance.
-
NovoCure has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is NovoCure Stock Undervalued?The current NovoCure [NVCR] share price is $21.71. The Score for NVCR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
NVCR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will NovoCure Stock Go Up Next Year?
-
Over the next 52 weeks, NovoCure has on average historically risen by 48.6% based on the past 9 years of stock performance.
NovoCure Stock Rating
Sell
30
NovoCure (NVCR)
is a Sell
Is NovoCure overpriced?
-
NovoCure has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
NovoCure Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Jersey
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
novocure.com
52-Week Data
52-Week High:
34.13
52-Week Low:
11.70
Prediction Charts
Market Cap:
2.3B
Price in USD:
21.71
Volume:
548.5K
Beta:
1.03
Technical Analysis
SMA50:
27.63
SMA100:
22.12
SMA200:
20.48
52-Wk Change:
45.51%
Stock Predictions
-
Is NovoCure stock public?Yes, NovoCure is a publicly traded company.
-
What is the NovoCure stock quote today?The NovoCure stock price is 21.71 USD today.
-
How to buy NovoCure stock online?You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-27 | 26.00 | 25.38 | 26.36 | 25.15 |
Jan-28 | 25.53 | 25.57 | 25.94 | 24.92 |
Jan-29 | 25.51 | 25.52 | 25.75 | 25.10 |
Jan-30 | 25.97 | 25.51 | 26.47 | 25.49 |
Jan-31 | 25.69 | 24.52 | 25.79 | 24.33 |
Feb-3 | 23.95 | 23.75 | 24.13 | 23.45 |
Feb-4 | 23.74 | 23.67 | 23.87 | 23.08 |
Feb-5 | 23.67 | 24.18 | 24.73 | 23.51 |
Feb-6 | 24.19 | 22.93 | 24.19 | 22.88 |
Feb-7 | 22.81 | 22.25 | 23.18 | 22.03 |
Feb-10 | 22.31 | 21.65 | 22.31 | 21.52 |
Feb-11 | 21.24 | 21.21 | 21.66 | 21.02 |
Feb-12 | 20.85 | 21.37 | 21.40 | 20.72 |
Feb-13 | 21.60 | 21.71 | 21.82 | 21.36 |
NovoCure Earnings
NovoCure Earnings Report: Per Share NovoCure Earnings Q1 Q2 Q3 and Q4 last year and next year.
NovoCure Forecast Revenue Growth
NovoCure Stock Analysis: Historical quarterly revenues per share for NovoCure and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.03 per share.
* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.